Ro vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Willow scores higher on our rubric, 7.5/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - our featured pick →or find your match

Willow beats Ro overall, scoring 7.5/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Ro is $149/mo membership + medication; Willow is from $299/mo. Choose Ro for users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing. Choose Willow for users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

A side-by-side look at Ro and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Ro

#38 of 54

7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro

Higher Rated

Willow

#20 of 54

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Ro	Willow
Why each one	The most trusted name in telehealth with the fastest prescription turnaround, same-day approval is standard, not the exception.	One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category.
Our Score	7.2/10	7.5/10
Headline Price	$149/mo membership + medication	from $299/mo
Medication Type	Brand	Compounded
Insurance Accepted	Yes	No
Best For	Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Watch out for	Membership and medication are billed separately, readers need to add them together for the all-in monthly cost	Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking	#38	#20
Get started	Visit Ro	Visit Willow

Pros & Cons Compared

Ro

Pros

+Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149-$349 depending on dose and refill timing via LillyDirect matching
+Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
+Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
+Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available

Cons

−Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
−Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
−Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Ro with a score of 7.5/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Ro is $149/mo membership + medication; Willow is from $299/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs.